Cite
Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli.
MLA
Abichabki, Nathália, et al. “Potential Cannabidiol (CBD) Repurposing as Antibacterial and Promising Therapy of CBD plus Polymyxin B (PB) against PB-Resistant Gram-Negative Bacilli.” Scientific Reports, vol. 12, no. 1, Apr. 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1038/s41598-022-10393-8.
APA
Abichabki, N., Zacharias, L. V., Moreira, N. C., Bellissimo-Rodrigues, F., Moreira, F. L., Benzi, J. R. L., Ogasawara, T. M. C., Ferreira, J. C., Ribeiro, C. M., Pavan, F. R., Pereira, L. R. L., Brancini, G. T. P., Braga, G. Ú. L., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. S., Lanchote, V. L., Cantón, R., Darini, A. L. C., & Andrade, L. N. (2022). Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, 12(1), 1–15. https://doi.org/10.1038/s41598-022-10393-8
Chicago
Abichabki, Nathália, Luísa V. Zacharias, Natália C. Moreira, Fernando Bellissimo-Rodrigues, Fernanda L. Moreira, Jhohann R. L. Benzi, Tânia M. C. Ogasawara, et al. 2022. “Potential Cannabidiol (CBD) Repurposing as Antibacterial and Promising Therapy of CBD plus Polymyxin B (PB) against PB-Resistant Gram-Negative Bacilli.” Scientific Reports 12 (1): 1–15. doi:10.1038/s41598-022-10393-8.